Caitong International Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152K Buy
+472
New +$146K 0.03% 455
2025
Q3
Sell
-219
Closed -$9.21K 2390
2025
Q2
$9.21K Buy
+219
New +$8.34K 0.01% 763

Other funds holding PRAX

Caitong International Asset Management's PRAX Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 472 shares worth $152K. The stake represents 0.03% of the portfolio and ranks #455 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in PRAX as recently as Q2 2025.

Caitong International Asset Management first reported a position in PRAX in Q2 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Caitong International Asset Management held 472 shares of Praxis Precision Medicines worth $152K as of Q1 2026.
  • Praxis Precision Medicines was a new Caitong International Asset Management position in Q1 2026.
  • Praxis Precision Medicines made up 0.03% of Caitong International Asset Management's portfolio in Q1 2026, its #455 holding.
  • Caitong International Asset Management first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.